Enterome

Industry · 8 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Terminated	EO4010 in Previously Treated Metastatic Colorectal Carcinoma Colorectal Cancer Metastatic	Phase 1 / Phase 2	2023-06-01
Terminated	EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Ca Colorectal Cancer	Phase 2	2023-03-01
Recruiting	A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgki Follicular Lymphoma, Marginal Zone Lymphoma	Phase 1 / Phase 2	2021-07-05
Terminated	A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Par Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma	Phase 1 / Phase 2	2020-07-23
Completed	First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblast Glioblastoma, Adult	Phase 1 / Phase 2	2020-07-13
Completed	A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients Crohn Disease	Phase 1	2018-03-07
Completed	First-in-Human Single and Multiple Dose of EB8018 Healthy Volunteers	Phase 1	2016-11-01
Terminated	MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Pati Crohn's Disease	N/A	2016-09-01